It was demonstrated that leptin receptors were plentiful in many types of cancer and that leptin–leptin receptor signaling played a key role in the promotion of several processes involved in cancer progression, such as the epithelial–mesenchymal transition, angiogenesis, metastasis and chemoresistance [12,13,42,44,45]. This evidence concerns the gene LEP and cancer.